CLSA retains sell rating on Ipca Labs, cuts earnings estimates News News / News 6 years ago 420 Views comments The firm slashed its FY18-19 earnings per share estimates by 15-30 percent to factor in challenging FY18 weak Q1FY18. Read more
News What changed for the market while you were sleeping? 15 things you should know News / News - 6 years ago
News More Chinese lenders plan to pursue Reliance Communications in insolvency court: Sources News / News - 6 years ago
News Stocks in the news: RIL, SBI, ITC, Rel Cap, SMS Pharma, Om Metal, Matrimony.com, NBCC News / News - 6 years ago
Comments